Truist Financial Increases HCA Healthcare (NYSE:HCA) Price Target to $520.00

HCA Healthcare (NYSE:HCA) had its price target boosted by investment analysts at Truist Financial from $495.00 to $520.00 in a research report issued to clients and investors on Monday,MarketScreener reports. The firm currently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 8.44% from the company’s previous close.

HCA has been the topic of a number of other research reports. TD Cowen lifted their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research note on Tuesday. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Finally, Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $480.32.

HCA Healthcare Price Performance

HCA stock opened at $479.52 on Monday. The company has a market capitalization of $109.42 billion, a P/E ratio of 18.50, a price-to-earnings-growth ratio of 1.29 and a beta of 1.36. The firm’s fifty day simple moving average is $478.99 and its 200-day simple moving average is $424.97. HCA Healthcare has a 12 month low of $295.00 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period last year, the firm earned $4.90 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current year.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.30% of the stock is owned by company insiders.

Institutional Trading of HCA Healthcare

Institutional investors have recently modified their holdings of the stock. Brighton Jones LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at $1,021,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after acquiring an additional 2,698 shares in the last quarter. NewEdge Advisors LLC increased its holdings in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares in the last quarter. Ascent Group LLC grew its holdings in HCA Healthcare by 9.1% in the first quarter. Ascent Group LLC now owns 9,607 shares of the company’s stock valued at $3,320,000 after purchasing an additional 799 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI acquired a new position in HCA Healthcare during the first quarter worth about $2,419,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.